Previous 10 | Next 10 |
BOONTON, N.J. , Dec. 6, 2019 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (SWKH.OB), congratulates Cara Therapeutics ...
The following slide deck was published by SWK Holdings Corporation in conjunction with this Read more ...
DALLAS , Nov. 21, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that Winston Black , Chief Executive Officer of SWK, has been named Chairman of the Company's Board of Directors...
SWK Holdings ( OTCQB:SWKH ): Q3 Non-GAAP EPS of $0.39; GAAP EPS of $0.32. Revenue of $6.35M (+8.0% Y/Y) Press Release More news on: SWK Holdings Corporation, Earnings news and commentary, Financial stocks news, ,
DALLAS , Nov. 18, 2019 /PRNewswire/ -- Corporate Highlights Acquired Enteris BioPharma, Inc. ("Enteris") a biotechnology company offering innovative formulation solutions utilizing its proprietary oral drug delivery technology, Peptelligence® Enteris to operate as an indepe...
DALLAS , Sept. 16, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held today in New York City . Details of SWK's prese...
DALLAS , Sept. 6, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its Board of Directors has authorized the Company to repurchase up to an aggregate of $2.1 million of the Compa...
DALLAS , Sept. 3, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, announced today that the Company has submitted its formal application to list its common shares on the NASDAQ Capital Market. Concu...
SWK Holdings ( OTCQB:SWKH ) announced a strategic acquisition whereby SWK, acquired 100% of Enteris' equity from Victory Park Capital. More news on: SWK Holdings Corporation, Merger & acquisition news, Read more ...
DALLAS and BOONTON, N.J. , Aug. 27, 2019 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, and Enteris BioPharma, Inc. ("Enteris"), a biotechnology company offering innovative formulation solutions uti...
News, Short Squeeze, Breakout and More Instantly...
SWK Holdings Corporation Company Name:
SWKH Stock Symbol:
OTCMKTS Market:
SWK Holdings Corporation Website:
Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of ...
2024-06-24 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate Highlights First quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023 First quarter 2024 finance r...